Gladstone Institutional Advisory »

Sarepta Therapeutics shares owned by Gladstone Institutional Advisory

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Gladstone Institutional Advisory from 13F filings

Historical chart of Gladstone Institutional Advisory investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Gladstone Institutional Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Gladstone Institutional Advisory

Quarter filed Position value Share count Share price at filing
2024-12-31 $9.0M 74k 121.59
2024-09-30 $10M 83k 124.89
2024-06-30 $8.9M 56k 158.00
2024-03-31 $7.3M 56k 129.46
2021-09-30 $227k 2.5k 92.46

More positions owned by Gladstone Institutional Advisory

Apple (AAPL)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Ser Tr Portfolio S&p500 (SPLG)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Purecycle Technologies (PCT)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Meta Platforms Cl A (META)

View all positions for Gladstone Institutional Advisory

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
Henderson Group
State Street Corporation
Farallon Capital Management
venBio Select Advisor
Bank of New York Mellon
Wellington Management Company
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
UBS Group
Groupama Asset Managment

View all funds holding Sarepta Therapeutics